Pharsight

Avondale Pharms patents expiration

1. Meloxicam patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6184220 AVONDALE PHARMS Oral suspension of pharmaceutical substance
Mar, 2019

(5 years ago)

US6184220

(Pediatric)

AVONDALE PHARMS Oral suspension of pharmaceutical substance
Sep, 2019

(4 years ago)

Drug Exclusivity Drug Exclusivity Expiration
Pediatric Exclusivity(PED) Feb 11, 2013
Orphan Drug Exclusivity(ODE) Aug 11, 2012

Drugs and Companies using MELOXICAM ingredient

Market Authorisation Date: 01 June, 2004

Treatment: NA

Dosage: SUSPENSION;ORAL

How can I launch a generic of MELOXICAM before it's drug patent expiration?
More Information on Dosage

MELOXICAM family patents

Family Patents